Skip to main content

1 in 7 volunteers for Sputnik V, Russia’s Covid-19 vaccine report side effects: Russian minister

By Unknown

One in seven volunteers complained of side effects after being injected with Sputnik V, Russia’s experimental vaccine against the coronavirus disease (Covid-19), the country’s health minister has said.

Mikhail Murashko, the Russian health minister, said more than 300 out of the announced 40,000 volunteers have been vaccinated with Sputnik V so far, according to the state-run TASS news agency.


“Approximately 14% have small complaints of weakness, muscle pain for 24 hours and an occasional increase in body temperature,” TASS quoted Murashko as saying on Wednesday, according to Moscow Times.


The minister said the symptoms after being injected with the anti-coronavirus vaccine “level off” by the next day. “The complications are described in the instructions and are predictable,” he said, according to TASS.


Volunteers are expected to receive a second shot of the adenovirus-based viral vector vaccine within 21 days of the first.


The Sputnik V has yet to complete large scale clinical trials but was approved by the Russian government last month, becoming the first Covid-19 vaccine to be cleared for human use anywhere in the world.


Final clinical trials of the Sputnik V vaccine began in Moscow earlier this month.


Scientists have, however, cautioned against the use of any shot that has not passed full safety and efficacy checks.


The Russian health minister’s comments came after the country’s sovereign wealth fund said it has reached an agreement with pharmaceuticals major Dr Reddy’s Laboratories for clinical trials and distribution of Sputnik V in India, a process that is yet to be cleared by the Drugs Controller General of India (DCGI).


Russian Direct Investment Fund (RDIF) has said it supply 100 million doses of the vaccine to Dr Reddy’s after regulatory approval in India. Indian officials said approvals will be given only after a thorough review.


Sputnik V did not lead to side effects and triggered an adequate immune response in 76 volunteers according to phase 1/2 trial data published in The Lancet journal earlier this month. But the results have been disputed by some scientists, who have sought a review of the data, citing what they said were striking similarities between patients.


RDIF reiterated on Wednesday that the vaccine is safe. “The Sputnik V vaccine, which is based on well-studied human adenoviral vector platform with proven safety, is undergoing clinical trials for the Coronavirus pandemic. Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India,” a statement said.


The Sputnik V is among several vaccine candidates being considered by Indian authorities for the country. Dr Balram Bhargava, the director general of the Indian Council of Medical Research (ICMR), earlier said that a high-level government committee was looking into the data coming from Russia on its Covid-19 vaccine.


Comments

Post a Comment

Popular posts from this blog

Increased risks of drop out for women and girls : CoronaVirus Updates

By Unknown
The total number of children not returning to their education after the school closures is likely to be significant. The pandemic also risks jeopardizing some of the gains made since 2001 in re-building women and girls’ education following the Taliban regime.  The COVID-19 pandemic is creating additional barriers due to risks—and students’ and parents’ anxiety about risks—associated with children returning to classrooms that are cramped, with no capacity for distancing, often cold, damp and poorly ventilated during the country’s severe winters, and have no or poor hygiene and clean water facilities. The COVID-19 pandemic is likely to drive many women and girls out of education permanently. School closures due to COVID-19, resulting increases in caregiving responsibilities for women and girls, and increases in poverty and unemployment will all make it harder for women and girls to study.  These factors combine in harmful ways with pre-existing discriminatory gender norms, o...
Post a Comment
Read more

No significant benefit of Umifenovir in COVID-19 treatment: Glenmark

By Unknown
Drug firm  Glenmark Pharmaceuticals  on Friday said the addition of  antiviral Umifenovir  did not demonstrate any significant clinical benefit over  Favipiravir  alone in  moderate COVID-19 patients .  The  clinical study  evaluated the possible superiority of the combination's efficacy against Favipiravir monotherapy, Glenmark said in a statement. As per the results that Glenmark presented to the regulator, the study showed no superior clinical outcomes with the addition of Umifenovir, it added. This was the second clinical study after the successful Favipiravir monotherapy trial earlier this year that led the company to receiving the Emergency Use Authorisation for Favipiravir, Glenmark said. "These latest findings confirm that the addition of Umifenovir does not show any incremental benefit in clinical outcomes. Thus Favipiravir therapy along with supportive care remains a suitable and effective choice for mild to moderate COVID-1...
Post a Comment
Read more

Context & pre-existing barriers to education for girls and women

By Unknown
Education is a right for all children and an educated population is essential for building a self-reliant, peaceful, equal, and inclusive Afghan society. Afghanistan’s education system has been severely impacted by decades of conflict, widespread poverty and humanitarian crisis.  Today, funding remains insufficient, as only 3% of Afghanistan’s Gross Domestic Product is allocated to education. International standards state that the government should spend at least 4 to 6% of GDP on education.  The Incheon Declaration and Framework for Action for the implementation of Sustainable Development Goal 4 recognizes that to “ensure inclusive and equitable quality education and promote lifelong learning opportunities for all”, least developed countries need to dedicate at least or more than 4 to 6%.  Afghanistan budgets far less than this, and even with this small percentage of funding the country’s education budget continues to be underspent every year.Afghanistan has one of the y...
Post a Comment
Read more